Podcasts about zadora

Parishioners of Annunciation of the Blessed Virgin Mary Catholic Church in St. Hedwig held a celebration May 26 in honor of the 50th anniversary of the ordination as a priest of their pastor, Rev. Boleslaw “Father Bill” Zadora. The event was attended by more than 325 priests, nuns, friends, and parishioners. The celebration included lunch, provided by Ronnie and Patty Kiolbassa. Following lunch, a brief biography of the life of Father Bill was delivered by Deacon Rick Coronado, who also served as Master of Ceremonies for the event. Boleslaw Zadora was born July 5, 1949, in Tokarivia, Poland. He is...Article Link

Po wybuchu wojny, na początku września 1939 roku na galarze Wisłą z Wawelu wyruszyła ekspedycja ratująca przed zniszczeniem skarby wawelskie, która dotarła w okolice Kazimierza Dolnego. Następnie na furmankach pamiątki narodowe były przewiezione przez gospodarzy do Karmanowic, skąd trafiłły przez Wąwolnicę, Wojciechów do Tomaszowic a stamtąd ciężarówkami przekroczyły 17 września granicę Polsko-Rumuńską. 83 lata później, grupa pasjonatów historii i miłośników dwóch kółek, wyruszyła rowerami z Karmanowic do Wojciechowa, śladami przewożenia skarbów wawelskich, chcąc uhonorować bohaterskich rolników. Na trasie między innymi odwiedzili ostatniego żyjącego uczestnika wyprawy, było wspólne słuchanie reportażu Marii Brzezińskiej z 1973 roku, którego bohaterami byli gospodarze ratujący skarby. Uczestnicy rajdu postanowili też odnaleźć miejsce postoju skarbów w Wojciechowie i rodzinę jednego z uczestników akcji przewożenia skarbów z okolic Wojciechowa. Są plany, aby w przyszłym roku, powstała na odcinku od Mięćmierza do Tomaszowic ścieżka rowerowa. A w audycji głos zabierają - Sławomir Snopek – prezes Regionalnego Towarzystwa Przyjaciół Wąwolnicy - Julian Karczmarczyk – ostatni żyjący uczestnik ratowania skarbów wawelskich, mieszkaniec Karmanowic - Bożena Zadora – córka pana Juliana - Lucyna Pardyka – wnuczka Antoniego Wrzesińskiego i Jana Grzegorczyka z Karmanowic, którzy brali udział w ratowaniu skarbów wawelskich - Ewa Kowalska – wnuczka Jana Chudzika z Gaju Nowego, który ratował skarby wawelskie - Wiesława Dybała – wieloletnia prezes Regionalnego Towarzystwa Przyjaciół Wąwolnicy - Jolanta Snopek – wicedyrektor Zespołu Szkolno-przedszkolnego w Wąwolnicy - Małgorzata Robak – dyrektor Szkoły Podstawowej imienia Stefana Żeromskiego w Karmanowicach - Michał Robak – mieszkaniec Karmanowic - Edyta Furtak i Alina Szumiata –z Towarzystwa Przyjaciół Wąwolnicy - Ewa Sokołowska – sołtys Wojciechowa - Kolonii Piątej i jej mąż Ryszard - Gerard Potakiewicz z Wąwolnicy i Andrzej Walasik z Puław- uczestnicy rajdu - Michał Orłowski i pani Beata - z Lublina miłośnicy wypraw rowerowych, których spotkaliśmy koło kuźni w Wojciechowie

In which the Mister and our buddy, Zach G, join me in reviewing VOYAGE OF THE ROCK ALIENS (1984), which is available on Tubi, but also for rent/buy on Prime. Written by Edward Gold, James Guidotti and Charles Hairston; the film is directed by James Fargo. The story follows a group of aliens (the band Rhema), who are out looking for the source of rock and roll music. They stumble upon our little planet and land in Speelburgh, a small town with a bunch of teens and the alien leader, Absid (Tom Nolan), becomes infatuated with Dee Dee (Pia Zadora). The story is devoid of plot and not much makes sense but there's a decent soundtrack which showcases Zadora, Rhema and the other featured band, Jimmy & The Mustangs. This is more a film for the nostalgia seekers and not meant to be taken seriously. The film has a run time of 1 h 37 m, and is rated PG, although there is a brief bit of nudity (topless woman). Please note there are SPOILERS in this review. Opening intro music: GOAT by Wayne Jones, courtesy of YouTube Audio Library. --- Support this podcast: https://anchor.fm/jokagoge/support

Hit The Link For More Info.https://linktr.ee/Djtank

which would you choose between Love and Money? Most youths are confused on which to choose between love and money. Love is a beautiful thing and so is money. We went to the streets of Uniben and guess what

ZaDora is the creator and primary clinician for now at Sankofa Center for Healing, LLC. She is a therapist, speaker, advocate for children and families, workshop facilitator and so much more. She has earned her Master's Degree in Social Work (MSW) from the University of Southern California. She is a Licensed Clinical Social Worker (LCSW). Her counseling philosophy honors the strengths you have, and your ability to be well and succeed. Over the seven years, she has been in the field of social work she has has the pleasure of serving children, adults, women, and families experiencing mental health challenges or life obstacles in community mental health agencies, residential facilities, non-profits, adolescent psychiatric hospitals, and private practice. ZaDora operates from a lens that understands sometimes we have to go back to ​our roots, our past, our upbringing and seek what has been lost, forgotten consciously and unconsciously to move forward. WE MUST GO BACK AND TAKE what is essential for a brighter future. ZaDora strives to help you build healthy relationships, greater sense of self, pride and skills to navigate some of life's obstacles. She is committed to reducing mental health stigma in African American communities and helping them heal. It is her goal to help improve black maternal health outcomes. She provides a culturally responsive client-centered, cognitive and strength-based approach to help you identify your strengths and provide therapeutic interventions that are specific to your individual needs. Her goal is to assist you on your Sankofa journey to a brighter and healthier future. --- Send in a voice message: https://anchor.fm/tlpedu/message Support this podcast: https://anchor.fm/tlpedu/support

which would you choose between Love and Money? Most youths are confused on which to choose between love and money. Love is a beautiful thing and so is money. We went to the streets of Uniben and guess what

After Heartbreak,What next? is an episode you should listen to, it entails the criteria for getting into a new relationship. Other episodes coming soon. What are the things you should include in your to-do list for a relationship. This episode is anchored by Zadora and a beautiful guest. You don't want to miss. Take a seat and a notepad. Learn something new.

In this episode, the gurls are joined by photographer Chantis Parks. They discuss the latest happenings in Washington, the passing of Cicely Tyson and Dustin Diamond, petty things they've done, and the group is divided on Emily in Paris and its Golden Globe nominations.

durée : 00:03:13 - La Chanson qui fait du bien France Bleu Cotentin

Connected with Zadora Williams, LCSW to discuss her path to social work, growing up in Chicago, healing, building her brand, mental health in the Black community, and much more! follow her on instagram @sankofa_cfh Check out the top 20 social work podcast on the web https://blog.feedspot.com/social_work_podcasts/ www.hiphopsocialworker.com Music by: Big Kurt the G.E.M Cash app for donations: $cscott85 Join the community of clinicians of color. Go to C4pdx.com for more information. Follow C4 on instagram: @c4pdx --- Support this podcast: https://anchor.fm/hip-hop-social-worker/support

Przygotowali Paweł Wadyl, Scrum Master oraz Mirosław Zadora, Senior Product Owner z Asseco Rzeszów Tutaj znajdziesz zapis video tego wystąpienia: https://www.facebook.com/watch/?v=234915677773663 Sprawdź też naszego bloga technologicznego: https://pl.asseco.com/kariera/blog/

Mars needs Santas and they are going to take ours along with the joy of Christmas for their own. Santa Claus Conquers the Martians (1964) is widely regarded as one of the worst movies of all time. It is so bad, it's good. We here at Invasion of the Remake love a good alien invasion and decided to remake the original film by mixing it with another 60's cult favorite...Mars Attacks! Find out how'd we'd rethink, recast and ultimately remake Santa Claus Conquers the Martians on this week's Invasion of the Remake. Sure to be a new Christmas classic!   Support independent podcasts like ours by telling your friends and family how to find us at places like Apple Podcasts, iTunes, Google Play Music, Stitcher, PlayerFM, Tune In Radio, RadioPublic, BluBrry, Libsyn, YouTube, iHeartRadio and all the best podcast providers. Spread the love! Like, share and subscribe! You can also help out the show with a positive review and a 5-star rating over on iTunes. We want to hear from you and your opinions will help shape the future of the show. Your ratings and reviews also help others find the show. Their "earballs" will thank you. Follow us on Twitter: @InvasionRemake Like and share us on Facebook & Instagram: Invasion of the Remake Email us your questions, suggestions, corrections, challenges and comments: invasionoftheremake@gmail.com

Dr. Carolyn Lam:               Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr. Carolyn Lam, associate editor from the National Heart Center, and Duke National University of Singapore.                                                 In just a moment, we will take a deep dive into the issue of age and its association with outcomes of primary prevention ICDs in patients with non-ischemic systolic heart failure.                                                 Yes, a long-awaited discussion from the Danish trial. That, in just a moment. First, here's your summary of this week's Journal.                                                 The first original paper provides evidence of a true association between disturbed genetic imprinting and Preeclampsia. This paper is from co-first authors, Dr. Zadora, and Dr. Singh, and co-corresponding authors, Dr. Izsvak, from the Max Delbrück Center for Molecular Medicine; Dr. Hurst, from the University of Bath; and Dr. Dechend, from the Experimental and Clinical Research Center of Berlin.                                                 These authors performed an unbiased analysis of genome-wide molecular data on raw characterized patient material, from normal controls, and patients with  Preeclampsia, and identified DLX-5 as an imprinted target gene, with novel placental function in Preeclampsia. Due to loss of imprinting, DLX5 was upregulated in 69% of placentas from Preeclampsia patients. Levels of DLX5 correlated with the classical Preeclampsia markers.                                                 DLX5 was expressed in human, but not in urine trophoblast, underlying the known human specificity of Preeclampsia. Finally, DLX5-induced overexpression if trophoblasts faithfully modeled Preeclampsia in a cell culture system. In summary, this paper shows that disturbed imprinting is common, and may play a causal role in Preeclampsia.                                                 The next study affirms that stenosis severity is better discriminated using coronary invasive physiologic indices, than using coronary angiographic assessment. First author, Dr. Lee, corresponding author Dr. Koo, colleagues of Seoul National University Hospital, studied 115 patients with left anterior descending artery stenosis, who underwent both ammonia positron emission tomography, or PET, an invasive physiologic measurement.                                                 Myocardial blood flow measured using PET, and invasively measured coronary pressures, were used to calculate microvascular resistance, and stenosis resistance. They found that both fractional flow reserve, or FFR, and instantaneous weight free ratio, or IFR, decreased as angiographic stenosis severity, resistance, and pressure gradient increased, and hyperemic myocardial blood flow decreased.                                                 When the presence of myocardial ischemia was defined by both low hyperemic myocardial blood flow, and low coronary flow reserve, the diagnostic accuracy of FFR and IFR did not differ, regardless of cutoff values for hyperemic myocardial blood flow, and CFR. However, at any given stratum of a given stenosis, physiologic classification of stenosis severity using FFR or IFR showed better discrimination of a unique relationship between absolute myocardial blood flow, and pressure gradient, than anatomic classification using angiographic percentage.                                                 In summary, by demonstrating coronary physiologic responses to coronary stenosis, these authors showed that stenosis severity is better discriminated, using invasive physiologic indices, than using angiographic assessment.                                                 The next paper identifies a previously unknown angiogenic growth factor that can be enhanced therapeutically to repair the heart after myocardial infarction. This novel growth factor is endoplasmic reticulum membrane complex, Subunit 10, or EMC10, which the authors previously identified by bioinformatic secretome analysis in bone marrow cells.                                                 In the current paper, from co-first authors Dr. [Rabel 00:04:35], and [Krof Clengobill 00:04:37], and corresponding author Dr. Wollert, from Hanover Medical Center, and colleagues, the authors investigated the angiogenic potential of EMC10, and its mouse homologue, in cultured endo fetal cells and infarcted heart explants. They found that EMC10 and its mouse homologue signal a virus, small GTAPases; p21-activated kinase; and p38 mitogen-activated protein kinase, to promote endothelial cell migration.                                                 In mice with acute myocardial infarction, bone marrow derived monocytes and macrophages produced EMC10 endogenously, to enhance infarct vascularization, tissue repair, and heart function. Furthermore, subcutaneous treatment with recombinant EMC10 for one week, after myocardial infarction, augmented infarct vascularization and repair, and led to a sustained improvement in heart function and survival.                                                 The next study is the first prospective randomized trial of screening for atrial fibrillation, with a smartphone-based, single-lead, electrocardiographic system in 1,001 patients, aged 65 years and above, with a CHA2DS2-VASc score of two and above, and without a history of atrial fibrillation.                                                 In this paper, from first and corresponding author Dr. Halcox, from Swansea University Medical School, in the United Kingdom, and colleagues, patients were randomized, either to biweekly electrocardiographic recordings with the iPhone device, or to routine over a 12-month period.                                                 The smartphone-based electrocardiographic approach was at least three times more likely to identify incident atrial fibrillation, than routine care, and at a cost of just over $10,000 per case identified, and was judged to be a highly acceptable approach in this group of patients. These results support consideration of evaluation in an appropriately-powered, event-driven randomized trial, to confirm the clinical and cost effectiveness of such an approach to stroke prevention in atrial fibrillation.                                                 Well, that wraps it up for your summaries. Now for our feature discussion. The Danish trial really created a huge splash last year, when it was reported that a primary prevention ICD in patients with non-ischemic systolic heart failure, may not actually reduce all cause mortality. Something that we had, perhaps, taken for granted, and in fact, entered our guidelines.                                                 Now, however, there was a pre-specified subgroup analysis at the time, that suggested a possible age-dependent association, between ICD and mortality, in the Danish trial. This week, we are so pleased to be discussing an in-depth analysis of the association between age and outcomes in the Danish trial.                                                 I'm so pleased to have the first author of today's featured paper, Dr. Marie Bayer Elming, of Copenhagen, Denmark, as well as Dr. Sana Al-Khatib, who's not only an associate editor of circulation, but also the author of an accompanying, and she is from Duke, Durham, North Carolina. Welcome, ladies! Dr. Bayer Elming:              Thank you. Happy to be here. Dr. Sana Al-Khatib:          Thank you so much. Dr. Carolyn Lam:               Sana, could you start by framing why this paper is so important, and why we've been looking forward in anticipation to these results? Dr. Sana Al-Khatib:          Absolutely. As you know, data on the outcomes of primary prevention ICDs in patients with non-ischemic cardiomyopathy started emerging in the early 2000s, or so. Then in 2005, the sudden cardiac deaths and heart failure trial was published, that included a large number of patients with non-ischemic cardiomyopathy, and absolutely showed survival benefits from primary prevention ICDs in those patients. Of course, there were also patients with ischemic cardiomyopathy.                                                 But really, that trial formed the basis of the guidelines, recommendations, that have informed our practice for the last 12 years, that basically tell us that we should consider implanting a primary prevention ICD in patients with non-ischemic cardiomyopathy, who have an EF of 35% or less, who have Class II or III heart failure symptoms. As long as they are on optimal care at the end, they have a reasonable life expectancy.                                                 So that's what's we've been doing for years, and then, the Danish trial was published this past year, that really called into question the prior findings, and the current practice. Because Danish, as you stated, showed no survival benefit with primary prevention ICDs, but there are many aspects about the trial that people need to pay attention to, to put the results in perspective.                                                 The fact that 58% of patients in the trial, in those arms, received cardiac resynchronization therapy ... the fact that the trial required that patients have an elevated NTproBMB level, to be considered for enrollment ... that may have biased the results toward a higher risk of non-sudden cardiac deaths, so on, so forth.                                                 I think what was really interesting, and caught people's attention, when the paper was published, was this subgroup analysis that showed that younger patients may benefit more than older patients. I think, many of us, Carolyn, were really awaiting the results of a more dedicated analysis, looking at age in Danish, and Dr. Elming and her colleagues did a great job looking at this very closely in their paper, and showed great results, and probably will let Dr. Elming share those results with us. Dr. Carolyn Lam:               Yes, absolutely, Sana. Actually, I just wanted to echo how surprised everyone was, and the immediate thing was, "Oh, my goodness. What do we do with the guidelines?" Maybe we should get back to that later, and Marie, please share with us, what did you do, and what did you find this time? Dr. Bayer Elming:              The reason why we did this study was that, in this main Danish trial, age was the only one of the 13 pre-specified subgroups that had a significant treatment by a subgroup interaction. This suggested that a younger patient might have a survival benefit from ICD ... the implication, even though the overall study was neutral. So we wanted to further investigate this relationship between age and effective ICD implantation.                                                 What we did was to look at the relation between age and effective ICD, and we found that there was this linear relation, for each year of younger age, that was associated with a reduction, a 3% reduction in the hazard ratio, for the benefit of ICD.                                                 Also, we did this selection impact curve, which is a bit technical, but what it does is to describe the expected survival for the population, on as a whole, for the different age cutoffs for ICD treatments.                                                 So, if we take into account, both the patients receiving an ICD, and those who did not, we could see why we would get the highest survival for the population as a whole. What we found was that, when no one in the population received an ICD, around 70% would survive.                                                 If everyone in the population received an ICD, only 72% would survive, but if we chose 70 years as the age cutoff ... so, patients younger than 70 years received an ICD, and patients older than 70 years did not receive an ICD, we got the highest survival for the population, and 75% would survive. Dr. Carolyn Lam:               Thank you, Marie. What important results. So, maybe, still consider ICDs for primary prevention ... in our non-ischemic systolic heart failure, patients were less than 70 years old. Is it as simple as that, Sana? You wrote a beautiful editorial. Tell us, what are the clinical implications? Dr. Sana Al-Khatib:          This is an important question. Danish was an important trial, but in my mind, it truly doesn't refute the role of primary prevention ICDs in patients with non-ischemic cardiomyopathy. As I mentioned earlier, the majority of patients enrolled in Danish received a CRT device. And so, you end up questioning, what does that actually mean, for those patients who are not eligible for cardiac resynchronization therapy?                                                 So, I actually believed that, and as you know, Carolyn, and maybe Marie knows, as well, there have been several meta analyses that have been published, combining data on patients with non-ischemic cardiomyopathy only, and excluding patients with cardiac resynchronization therapy from Danish, that have actually now shown, consistently, a significant improvement in survival, with a primary prevention ICD ... including one that was done by our group.                                                 So, no, I don't think that, based on the results, we should say, "No, we shouldn't be offering primary prevention ICDs to patients with non-ischemic cardiomyopathy," and this beautiful analysis that was done by Marie and her group actually shows that, at least for those patients who are 70 years of age and younger, I think we should absolutely continue to consider them for the therapy, and offer them the therapy, if they're appropriate candidates.                                                 Then, of course, if the patients are older than 70,, and they meet criteria for cardiac resynchronization therapy, I think it will be important for us to be talking to the patients about ... is the RTD with a defibrillator, versus a CRTP only, with a pacemaker, and talking about the pros and cons, and everything else? But in those patients who are older than 70, who don't meet criteria for CRT, I think more research is needed, to really understand the role of primary prevention ICDs in those patients. We definitely need more data there. Dr. Bayer Elming:              I definitely agree that, of course, for the patients older than 70 years were not candidates for CRT treatment. These patients, we do not know very much about 'em, and this study that we did, do not answer that question. Based on the Danish study, and this further analysis of the age inspection, the guidelines in Denmark also state that patients younger than, we say, 68 years, because that was the age cutoff used in the '08 Danish trial, you should definitely think of giving patients with non-ischemic cardiomyopathy an ICD.                                                 But for the older patients, it depends on a variety of co-factors, such as co-morbidity, or frailty, and it should be an individual assessment of the patient. So, I agree with you, Sana. Dr. Carolyn Lam:               That's wonderful. Hey, just one more question. Sana, I'd like you to put on your AE hat, now, and sort of think with me. In circulation, we don't ... well, we're careful about publishing subgroup analyses, so to speak, right, of results. You articulated, in your editorial, reasons why this, perhaps subgroup analysis, may be different from others. Could you elaborate on that a bit? Dr. Bayer Elming:              Yeah, and absolutely, that's a great question. As you pointed out, I mean, you really ... the conventional wisdom in clinical research is to be careful, interpreting subgroup analyses. I think there are some strengths in this particular analysis, as Marie stated: "Here's what we specified." The other thing is, I believe that Marie and her group then came, and did their very robust statistical methods, and really, probably most importantly, if you look at their findings, they actually really align well, and support their main conclusion.                                                 For example, looking at the fact that older patients had the higher presence of co-morbidities, that they had a higher level of [Co-BMP 00:17:00], they had had a longer duration of heart failure ... I mean, all those things most likely had an impact on their mode of death, really making it more likely for those patients to succumb to non-sudden cardiac death. I think the whole story makes a lot of sense. Dr. Bayer Elming:              If I can elaborate a bit on this, I think one of the important findings from the study is that we show that mode of death varied according to age. So, the rates of sudden cardiac death were almost similar, between the younger and the older part of the population. But the rates of non-sudden death were almost twice as high in the older part of the population. This is a really good explanation why the ICD implantations have less impact in the older patients. Dr. Carolyn Lam:               Yeah, because ICDs would definitely not be expected to reduce non-sudden cardiac deaths. Really, really, well put. Oh, thank you so much, Marie. We're so proud to be publishing your beautiful paper, as well as your editorial, Sana, and thank you for this great conversation.                                                 Well, listeners, I'm sure you enjoyed that as much as I did. Thank you for joining us this week, and don't forget to tune in next week.

Cavemen, Charles Bronson, and the motherlovin' Swamp Thing! We are off and running with the second month of our third season of the program, and now we're really cooking. Look at how diverse this month's titles are: We've got a great little-seen Western starring Gary Busey and Willie Nelson. We've got a passion project (and you know what that means) from the Oscar-winning writer of The Sting. We've got the passion project to end all passion projects (and you definitely know what that means) from the Oscar-winning director of The Godfather. And you want a submarine movie? OF COURSE YOU DO. AND YOU WILL LOVE IT. Roger Daltrey. Hot air balloons. And Pia freakin' Zadora. Stop reading. Start listening. It's February 1982.

Do you want all the amazing stories from The Voyage of the Rock Aliens production? Well you've come to the right place. After receiving a transmission from space, the guys managed to get two of the rock aliens to agree to an interview on the Grindbin! Marc Jackson and Jeffrey Casey join us and share all the things you ever wanted to know about what happened behind the scenes of one of the strangest musicals ever made. You can find the new RHEMA album on Itunes: https://itunes.apple.com/us/artist/rhema/id1229422507

Esta vez nuestro repaso a artistas y bandas, que no llegaron a triunfar del todo, tiene un cariz internacional. Esta vez podréis encontrar personalidades coyunturales que decidieron dar el salto a la canción como Vanity, Pía Zadora o Vanity o verdaderos precursores del grunge o del britpop como Stiltksin o The La's. Pero también bandas de hair metal tan olímpicas como Nitro, combos prefabricados como Sigue Sigue Sputnik o pìoneras del hip hop femenino como Tairrie B. Incluso supergrupos como Tinted Windows, la mujer del Rolling Stone Bill Wyman o incluso una banda que tuvo un éxito con una versión heavy del cuento de los tres cerditos. Otra vez rastreamos el destino de artistas y bandas que no aparecerán en ningún recopilatorio de Lo Mejor de los 80 y se nos suma el nuetro amigo Julián Almazán de Teenage Thunder

Esta vez nuestro repaso a artistas y bandas, que no llegaron a triunfar del todo, tiene un cariz internacional. Esta vez podréis encontrar personalidades coyunturales que decidieron dar el salto a la canción como Vanity, Pía Zadora o Vanity o verdaderos precursores del grunge o del britpop como Stiltksin o The La's. Pero también bandas de hair metal tan olímpicas como Nitro, combos prefabricados como Sigue Sigue Sputnik o pìoneras del hip hop femenino como Tairrie B. Incluso supergrupos como Tinted Windows, la mujer del Rolling Stone Bill Wyman o incluso una banda que tuvo un éxito con una versión heavy del cuento de los tres cerditos. Otra vez rastreamos el destino de artistas y bandas que no aparecerán en ningún recopilatorio de Lo Mejor de los 80 y se nos suma el nuetro amigo Julián Almazán de Teenage Thunder